セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/11/10 | 4,205 | 4,400 | 4,195 | 4,260 | +50 | +1.2% | 82,300 |
| 2022/11/09 | 4,285 | 4,285 | 4,185 | 4,210 | -35 | -0.8% | 60,000 |
| 2022/11/08 | 4,260 | 4,355 | 4,190 | 4,245 | -10 | -0.2% | 67,300 |
| 2022/11/07 | 4,295 | 4,300 | 4,210 | 4,255 | ±0 | ±0% | 56,600 |
| 2022/11/04 | 4,360 | 4,375 | 4,220 | 4,255 | -95 | -2.2% | 60,800 |
| 2022/11/02 | 4,325 | 4,410 | 4,305 | 4,350 | -15 | -0.3% | 42,000 |
| 2022/11/01 | 4,430 | 4,435 | 4,345 | 4,365 | -30 | -0.7% | 41,900 |
| 2022/10/31 | 4,445 | 4,490 | 4,365 | 4,395 | +45 | +1% | 80,500 |
| 2022/10/28 | 4,250 | 4,385 | 4,205 | 4,350 | +100 | +2.4% | 71,200 |
| 2022/10/27 | 4,320 | 4,330 | 4,240 | 4,250 | -65 | -1.5% | 66,800 |
| 2022/10/26 | 4,310 | 4,400 | 4,290 | 4,315 | +60 | +1.4% | 100,600 |
| 2022/10/25 | 4,255 | 4,290 | 4,160 | 4,255 | +15 | +0.4% | 80,900 |
| 2022/10/24 | 4,275 | 4,315 | 4,190 | 4,240 | +105 | +2.5% | 112,000 |
| 2022/10/21 | 4,190 | 4,215 | 4,125 | 4,135 | -110 | -2.6% | 72,100 |
| 2022/10/20 | 4,170 | 4,275 | 4,130 | 4,245 | +15 | +0.4% | 103,500 |
| 2022/10/19 | 4,400 | 4,420 | 4,230 | 4,230 | -120 | -2.8% | 77,200 |
| 2022/10/18 | 4,300 | 4,430 | 4,300 | 4,350 | +150 | +3.6% | 134,500 |
| 2022/10/17 | 4,140 | 4,210 | 4,085 | 4,200 | ±0 | ±0% | 76,100 |
| 2022/10/14 | 4,230 | 4,250 | 4,160 | 4,200 | +110 | +2.7% | 88,800 |
| 2022/10/13 | 4,220 | 4,230 | 4,050 | 4,090 | -125 | -3% | 141,100 |
| 2022/10/12 | 4,325 | 4,340 | 4,205 | 4,215 | -130 | -3% | 111,100 |
| 2022/10/11 | 4,490 | 4,515 | 4,345 | 4,345 | -195 | -4.3% | 121,500 |
| 2022/10/07 | 4,675 | 4,705 | 4,530 | 4,540 | -205 | -4.3% | 169,900 |
| 2022/10/06 | 4,515 | 4,750 | 4,490 | 4,745 | +240 | +5.3% | 251,600 |
| 2022/10/05 | 4,510 | 4,585 | 4,485 | 4,505 | +25 | +0.6% | 136,600 |
| 2022/10/04 | 4,550 | 4,610 | 4,440 | 4,480 | +20 | +0.4% | 131,400 |
| 2022/10/03 | 4,370 | 4,490 | 4,240 | 4,460 | +70 | +1.6% | 90,200 |
| 2022/09/30 | 4,360 | 4,445 | 4,325 | 4,390 | -40 | -0.9% | 94,300 |
| 2022/09/29 | 4,415 | 4,495 | 4,355 | 4,430 | +155 | +3.6% | 154,700 |
| 2022/09/28 | 4,335 | 4,475 | 4,240 | 4,275 | -85 | -1.9% | 123,500 |
| 2022/09/27 | 4,300 | 4,470 | 4,270 | 4,360 | +60 | +1.4% | 125,900 |
| 2022/09/26 | 4,180 | 4,325 | 4,075 | 4,300 | +60 | +1.4% | 146,000 |
| 2022/09/22 | 4,150 | 4,280 | 4,100 | 4,240 | +45 | +1.1% | 131,400 |
| 2022/09/21 | 4,150 | 4,240 | 4,105 | 4,195 | +5 | +0.1% | 182,800 |
| 2022/09/20 | 4,490 | 4,530 | 4,155 | 4,190 | -275 | -6.2% | 398,100 |
| 2022/09/16 | 4,750 | 4,760 | 4,450 | 4,465 | -300 | -6.3% | 376,200 |
| 2022/09/15 | 5,010 | 5,100 | 4,760 | 4,765 | -335 | -6.6% | 410,600 |
| 2022/09/14 | 4,760 | 5,200 | 4,715 | 5,100 | +210 | +4.3% | 543,300 |
| 2022/09/13 | 5,050 | 5,060 | 4,805 | 4,890 | -130 | -2.6% | 251,900 |
| 2022/09/12 | 4,890 | 5,030 | 4,850 | 5,020 | +180 | +3.7% | 214,400 |
| 2022/09/09 | 4,650 | 4,840 | 4,645 | 4,840 | +240 | +5.2% | 158,100 |
| 2022/09/08 | 4,640 | 4,670 | 4,550 | 4,600 | +5 | +0.1% | 98,800 |
| 2022/09/07 | 4,685 | 4,715 | 4,450 | 4,595 | -120 | -2.5% | 193,500 |
| 2022/09/06 | 4,805 | 4,955 | 4,650 | 4,715 | -75 | -1.6% | 251,500 |
| 2022/09/05 | 4,850 | 4,915 | 4,770 | 4,790 | -75 | -1.5% | 144,100 |
| 2022/09/02 | 5,110 | 5,200 | 4,780 | 4,865 | -165 | -3.3% | 417,000 |
| 2022/09/01 | 5,250 | 5,340 | 5,000 | 5,030 | +305 | +6.5% | 688,200 |
| 2022/08/31 | 4,660 | 4,760 | 4,540 | 4,725 | +55 | +1.2% | 111,900 |
| 2022/08/30 | 4,595 | 4,680 | 4,585 | 4,670 | +100 | +2.2% | 96,700 |
| 2022/08/29 | 4,600 | 4,730 | 4,520 | 4,570 | -160 | -3.4% | 144,200 |
501～
550
件表示中 / 1240件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| ミズホメディ | 163,000円 | -5.1% | -21.2% | 4.91% | 10.29倍 | 1.96倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| 扶桑薬 | 266,000円 | +8.3% | +98.1% | 3.08% | 8.74倍 | 0.60倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
市場注目の銘柄
チャート関連のコラム
